We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ecolab (ECL) Teams Up with Microsoft to Upgrade Water Tool
Read MoreHide Full Article
St. Paul, MN-based Ecolab Inc. (ECL - Free Report) , a leading provider of water, hygiene and energy technologies and services, announced that it has collaborated with Microsoft Corp. (MSFT - Free Report) to upgrade its financial-modeling tool, Water Risk Monetizer.
Stock Performance
The price performance of the stock has been unfavorable over the last three months. Ecolab registered a return of 4.56%, underperforming the Zacks classified Chemical-Specialty sub-industry’s gain of almost 6.69%.
Also, the estimate revision trend for the current year has been unfavorable as eight estimates moved south over the last two months compared with three movements in the opposite direction. Thus, investors are waiting for a reversal in estimates before adding the stock. This justifies the stock’s Zacks Rank #3 (Hold).
Details of Water Tool
Coming back to the news, the Water Risk Monetizer tool is designed to aid businesses conserve water and predict water expenses. The upgrade would provide customers with extra analytical data regarding any impairment — like solids, unwanted nutrients such as ammonia, or salt water — in their water supply. The tool was launched in 2014. Ecolab developed the product using environmental data and risk analysis from Trucost.
We believe that with the added water quality risk tool, the Water Risk Monetizer will be used by more businesses. We are also bullish on Ecolab’s growing focus on water management and conservation, innovative product portfolio and strategic acquisitions. Notably, the global water treatment and chemicals market markets are expected to reach $24.94 billion by 2020, growing at a CAGR of 4.5% (Markets And Markets).
Furthermore, Ecolab boasts compelling fundamentals with revenues and adjusted earnings multiplying at a rate of 4.6% and 13.7%, over the last three years.
Stocks to Consider
Better-ranked stocks in the broader medical sector include Inogen Inc. (INGN - Free Report) and Fluidigm Corporation . Notably, Inogen sports a Zacks Rank #1 (Strong Buy) while Fluidigm carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Inogen has a long-term expected earnings growth rate of 17.05%. Notably, the stock registered an impressive one-year return of 82%.
Fluidigm Corporation has a long-term expected earnings growth rate of 25%. The stock delivered a positive earnings surprise of 1.6% in the last reported quarter.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020. Click here for the 6 trades >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Ecolab (ECL) Teams Up with Microsoft to Upgrade Water Tool
St. Paul, MN-based Ecolab Inc. (ECL - Free Report) , a leading provider of water, hygiene and energy technologies and services, announced that it has collaborated with Microsoft Corp. (MSFT - Free Report) to upgrade its financial-modeling tool, Water Risk Monetizer.
Stock Performance
The price performance of the stock has been unfavorable over the last three months. Ecolab registered a return of 4.56%, underperforming the Zacks classified Chemical-Specialty sub-industry’s gain of almost 6.69%.
Also, the estimate revision trend for the current year has been unfavorable as eight estimates moved south over the last two months compared with three movements in the opposite direction. Thus, investors are waiting for a reversal in estimates before adding the stock. This justifies the stock’s Zacks Rank #3 (Hold).
Details of Water Tool
Coming back to the news, the Water Risk Monetizer tool is designed to aid businesses conserve water and predict water expenses. The upgrade would provide customers with extra analytical data regarding any impairment — like solids, unwanted nutrients such as ammonia, or salt water — in their water supply. The tool was launched in 2014. Ecolab developed the product using environmental data and risk analysis from Trucost.
We believe that with the added water quality risk tool, the Water Risk Monetizer will be used by more businesses. We are also bullish on Ecolab’s growing focus on water management and conservation, innovative product portfolio and strategic acquisitions. Notably, the global water treatment and chemicals market markets are expected to reach $24.94 billion by 2020, growing at a CAGR of 4.5% (Markets And Markets).
Furthermore, Ecolab boasts compelling fundamentals with revenues and adjusted earnings multiplying at a rate of 4.6% and 13.7%, over the last three years.
Stocks to Consider
Better-ranked stocks in the broader medical sector include Inogen Inc. (INGN - Free Report) and Fluidigm Corporation . Notably, Inogen sports a Zacks Rank #1 (Strong Buy) while Fluidigm carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Inogen has a long-term expected earnings growth rate of 17.05%. Notably, the stock registered an impressive one-year return of 82%.
Fluidigm Corporation has a long-term expected earnings growth rate of 25%. The stock delivered a positive earnings surprise of 1.6% in the last reported quarter.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere
1 billion iPhones in 10 years but a new breakthrough is expected to generate more
than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging
phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020. Click here for the 6 trades >>